Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future
出版年份 2018 全文链接
标题
Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume 64, Issue s1, Pages S3-S22
出版商
IOS Press
发表日期
2018-03-16
DOI
10.3233/jad-179901
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
- (2018) Eric M. Reiman et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β1-15/16 as a Marker for γ-Secretase Inhibition in Alzheimer's Disease
- (2018) Erik Portelius et al. JOURNAL OF ALZHEIMERS DISEASE
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The target product profile as a tool for regulatory communication: advantageous but underused
- (2017) Adria Tyndall et al. NATURE REVIEWS DRUG DISCOVERY
- Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non–Alzheimer Disease Pathophysiology
- (2017) Stefanie Schreiber et al. JAMA Neurology
- Molecular inflation, attrition and the rule of five
- (2016) Paul D. Leeson ADVANCED DRUG DELIVERY REVIEWS
- Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials
- (2016) Jeff Sevigny et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials
- (2016) Ronald G. Thomas et al. Alzheimers & Dementia
- Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease
- (2016) Antonio Giuliano Zippo et al. Current Alzheimer Research
- Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms
- (2016) Claudio Babiloni et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
- (2016) Jinping Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Phase II and phase III failures: 2013–2015
- (2016) Richard K. Harrison NATURE REVIEWS DRUG DISCOVERY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans
- (2016) Mikko Hölttä et al. Alzheimers Research & Therapy
- Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
- (2016) Liang Wang et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Rodent models for Alzheimer’s disease drug discovery
- (2015) Daniela Puzzo et al. Expert Opinion on Drug Discovery
- A framework to assess the value of subgroup analyses when the overall treatment effect is significant
- (2015) Hong Sun et al. Journal of Biopharmaceutical Statistics
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum
- (2015) Ying Liu et al. MOLECULAR NEUROBIOLOGY
- Alzheimer’s disease progression by geographical region in a clinical trial setting
- (2015) David B Henley et al. Alzheimers Research & Therapy
- Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials
- (2015) Joshua D Grill et al. Alzheimers Research & Therapy
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- The Impact of Preclinical Irreproducibility on Drug Development
- (2015) LP Freedman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease
- (2015) Hong Liu-Seifert et al. PLoS One
- An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
- (2014) Jessica B. Langbaum et al. Alzheimers & Dementia
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Economic analysis of opportunities to accelerate Alzheimer's disease research and development
- (2014) Troy J. Scott et al. Annals of the New York Academy of Sciences
- Adaptive Clinical Trial Design
- (2014) Shein-Chung Chow Annual Review of Medicine
- Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents
- (2014) Pravin Ambure et al. Expert Opinion on Drug Discovery
- How to Use a Subgroup Analysis
- (2014) Xin Sun et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CNS Amyloid- , Soluble APP- and - Kinetics during BACE Inhibition
- (2014) J. A. Dobrowolska et al. JOURNAL OF NEUROSCIENCE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- A three-dimensional human neural cell culture model of Alzheimer’s disease
- (2014) Se Hoon Choi et al. NATURE
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- Effect of Potent γ-Secretase Modulator in Human Neurons Derived From Multiple Presenilin 1–Induced Pluripotent Stem Cell Mutant Carriers
- (2014) Qing Liu et al. JAMA Neurology
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- A Map of Alzheimer’s Disease–Signaling Pathways: A Hope for Drug Target Discovery
- (2013) S Ogishima et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
- (2013) Brian Appleby et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A Review: Treatment of Alzheimers Disease Discovered in Repurposed Agents
- (2013) Brian S. Appleby et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Experimental models for predicting drug absorption and metabolism
- (2013) Saeed Alqahtani et al. Expert Opinion on Drug Metabolism & Toxicology
- Utility of CSF in translational neuroscience
- (2013) Elizabeth C. M. de Lange JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Blood–brain-barriers in aging and in Alzheimer’s disease
- (2013) Fernanda Marques et al. Molecular Neurodegeneration
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Innovation in Therapeutics Development at the NCATS
- (2013) Christine M Colvis et al. NEUROPSYCHOPHARMACOLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
- (2013) S.M. Mills et al. REVUE NEUROLOGIQUE
- Animal Models of Alzheimer Disease
- (2013) F. M. LaFerla et al. Cold Spring Harbor Perspectives in Medicine
- Epidemiology of Dementias and Alzheimer’s Disease
- (2012) Ana Luisa Sosa-Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimers Disease
- (2012) Jeffrey Cummings et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
- (2012) Masahisa Katsuno et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
- (2012) Joshua D. Grill et al. NEUROBIOLOGY OF AGING
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
- (2011) William A. Banks ADVANCED DRUG DELIVERY REVIEWS
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
- (2011) Martin Farlow et al. BMC Neurology
- Structure-based druggability assessment—identifying suitable targets for small molecule therapeutics
- (2011) Eric B Fauman et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Antibody-based therapy in Alzheimer's disease
- (2011) Refik Pul et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Key Concepts of Clinical Trials: A Narrative Review
- (2011) Craig A. Umscheid et al. POSTGRADUATE MEDICINE
- Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
- (2011) Diana W Shineman et al. Alzheimers Research & Therapy
- Globalization of Alzheimer's disease clinical trials
- (2011) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Principles of early drug discovery
- (2010) JP Hughes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Functional Alterations in Memory Networks in Early Alzheimer’s Disease
- (2010) Reisa A. Sperling et al. NEUROMOLECULAR MEDICINE
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Translational Medicine Lessons from Flurizan's Failure in Alzheimer's Disease (AD) Trial: Implication for Future Drug Discovery and Development for AD
- (2009) Hong I. Wan et al. CTS-Clinical and Translational Science
- Exploratory drug safety: A discovery strategy to reduce attrition in development
- (2009) Alan S. Bass et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Optimizing phase II of drug development for disease-modifying compounds
- (2008) Jeffrey L. Cummings Alzheimers & Dementia
- High-content analysis in neuroscience
- (2008) Mike Dragunow NATURE REVIEWS NEUROSCIENCE
- MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
- (2008) J. L. Whitwell et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation